Neuronetics, Inc.
STIM•NASDAQ•Healthcare•Medical Devices

About Neuronetics

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Company Information

SectorHealthcare
IndustryMedical Devices
CEOKeith Sullivan
Founded2003
IPO DateJune 28, 2018
Employees716
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websiteneurostar.com/neuronetics
Phone610 640 4202
Address
3222 Phoenixville Pike Malvern, Pennsylvania 19355 United States

Corporate Identifiers

CIK0001227636
CUSIP64131A105
ISINUS64131A1051
SIC3841

Leadership Team & Key Executives

Stephen J. Furlong M.S.
Senior Advisor to the Chief Executive Officer
Keith J. Sullivan
President, Chief Executive Officer and Director
W. Andrew Macan J.D.
EVice President, Chief Legal Officer and Corporate Secretary
Steven E. Pfanstiel C.M.A., M.B.A.
Executive Vice President, Treasurer and Chief Financial Officer
Jeffrey S. Jones
Senior Vice President and Chief of Operations
Cory S. Anderson
SVice President and Chief Technology Officer
Lisa Metzner-Rosas
Senior Vice President and Chief Marketing Officer
Sara Grubbs
Senior Vice President and Chief Revenue Officer
William P. Leonard
Chief Clinic Officer